February 15, 2018 / 2:16 PM / 10 months ago

BRIEF-Prometic Granted Orphan Drug Designation By FDA

Feb 15 (Reuters) - Prometic Life Sciences Inc:

* PROMETIC GRANTED ORPHAN DRUG DESIGNATION BY FDA FOR INTER-ALPHA-INHIBITOR-PROTEINS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS (NEC)

* PROMETIC LIFE SCIENCES INC - ORPHAN DRUG DESIGNATION STATUS HAS BEEN GRANTED TO ITS IAIP FOR TREATMENT OF NECROTIZING ENTEROCOLITIS BY U.S. FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below